Evolution of the protection system for traditional Chinese medicine varieties and the strategic responses of traditional Chinese medicine enterprises

Abstract

The protection system for traditional Chinese medicine (TCM) varieties, as an important policy tool to promote the development of TCM, has a long history of over 30 years, from the promulgation of the “Regulations on the Protection of Traditional Chinese Medicine Varieties” in 1992 to the comprehensive revision of the draft for soliciting opinions in 2022. The TCM protection system evolves to meet the needs of innovative development of TCM. This paper reviews the policy developments in TCM varieties protection, collates protection data (1993 to 2024), and analyzes enterprises application strategies amid impending regulatory changes.

Keywords

protection of traditional Chinese medicine (TCM) varieties / policy evolution / the exclusive logo of TCM protection / patent and TCM protection integration / intelligent manufacturing and internationalization

References

[1] National People’s Congress. Traditional Chinese Medicine Law of the People’s Republic of China. http://www.npc.gov.cn/zgrdw/npc/xinwen/2016-12/25/content_2004972.htm [12/25/2016].

[2] Ministry of Industry and Information Technology & State Administration of Traditional Chinese Medicine, et al. Protection and development plan for Chinese herbal medicines. https://www.gov.cn/xinwen/2015-04/27/content_2853739.htm [04/27/2015].

[3] Central People’s Government of the People’s Republic of China. Regulations on the protection of traditional Chinese medicine varieties. https://www.gov.cn/gongbao/content/2019/content_5468846.htm [12/31/2019].

[4] National Medical Products Administration. Public consultation on the revised regulations on the protection of traditional Chinese medicine varieties. https://www.nmpa.gov.cn/xxgk/zhqyj/zhqyjyp/20221223171015116.html [12/23/2022].

[5] State Food and Drug Administration. Notice on issuing guidelines for the protection of traditional Chinese medicine varieties. https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20090203120001961.html [02/03/2009].

[6] He Q, Ma SC. A review of the implementation of the Regulations on the Protection of Traditional Chinese Medicine Varieties over the past 30 years. Chin Pharm J, 2023, 58: 2209-2212.

[7] Cao MD, Wu R, Wang Z, et al. Variety, indications, and medication characteristics of approved traditional Chinese medicine products in China. Chin Pat Med, 2019, 41: 1999-2006.

[8] Zhang RX. Analysis of the relationship between brand awareness, recognition, satisfaction, and brand loyalty. Chin Mark, 2021, 31: 7-9.

[9] Yang L. Discussion on the important role of ISO 9001 quality management system certification in enterprise management. Chin Collect Econ, 2017, 4: 33-34.

[10] Ma SJ, Tu QW. Overview of China’s mandatory product certification. Reliab Environ Test Electron Prod, 2021, 39: 102-107.

[11] Teng F. The role of the food industry in promoting local economic development: Review of green food industry development and green marketing in China. J Food Saf Qual. 2023, 12: 308.

[12] Su XY. A review of factors influencing consumer purchasing behavior for OTC drugs in retail pharmacies. Shang Xun, 2020, 20: 161-162.

[13] National Medical Products Administration. Implementation opinions on promoting the inheritance and innovative development of traditional Chinese medicine. https://www.gov.cn/zhengce/zhengceku/2020-12/26/content_5573463.htm [12/21/2020].

[14] Supreme People’s Court. Opinions on strengthening judicial protection of intellectual property rights in traditional Chinese medicine. https://www.court.gov.cn/zixun/xiangqing/384041.html [12/22/2022].

[15] Center for Drug Evaluation, National Medical Products Administration. Annual report on the progress of clinical trials for new drug registration in China (2022). https://www.cde.org.cn/main/news/viewInfoCommon/849b5a642142fc00738aff200077db11 [09/07/2023].

[16] Pan W. Analysis of the priority examination system for patent applications—Another tool for applicants to accelerate their patent strategy layout. China Invent Patent, 2012, 9: 70-71.

[17] Zhou J, Mao J. Preliminary study on a comprehensive intellectual property protection system for innovative traditional Chinese medicine—An empirical analysis based on the Lianhua Qingwen formula of Yiling Pharmaceutical. Chin J New Drugs, 2024, 33: 745-751.